title: Optimal P2Y12 Inhibitor for Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Network Meta-Analysis in the Data-Free Zone: Do You Believe in Magic?
authors.affiliation: Division of Cardiology, Timone Hospital and INSERM UMR 1062, INRA UMR 1260, Aix-Marseille University, Marseille, France.
authors.forename: Thomas
authors.initials: T
authors.lastname: Cuisset
authors.affiliation: Cardio-Thoracic-Vascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy.
authors.forename: Davide
authors.initials: D
authors.lastname: Capodanno
authors.affiliation: Cardiovascular Research Center Aalst, Aalst, Belgium; Lambe Institute for Translational Medicine and Curam, National University of Ireland, Galway and Saolta University Healthcare Group, Galway, Ireland. Electronic address: william.wyns@gmail.com.
authors.forename: William
authors.initials: W
authors.lastname: Wijns
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D006801:Humans; D009203:Myocardial Infarction; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000072657:ST Elevation Myocardial Infarction; D016896:Treatment Outcome; D000071076:Network Meta-Analysis as Topic
chemical_list: D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex
keywords: STEMI; antiplatelet treatment; glycoprotein IIb-IIIa antagonists; primary PCI